Tag: Jim Shannon

The below Parliamentary question was asked by Jim Shannon on 2016-09-12.

To ask the Secretary of State for Foreign and Commonwealth Affairs, what steps the Government is taking to promote private sector investment in Kurdistan.

Mr Tobias Ellwood

In recognition of the potential investment opportunities in Iraq as a whole, the Department for International Trade has recently finalised an ambitious five-year Business Plan. That plan seeks to underpin the promotion of British trade across Iraq, including the Kurdistan Region of Iraq (KRI), to deliver maximum export opportunities for UK companies and ensure that we take advantage of the opportunities that the KRI market offers.

The below Parliamentary question was asked by Jim Shannon on 2016-09-13.

To ask the Secretary of State for Defence, how many Army Reserves who did not pass the annual mandatory training test in 2015 were deployed on operation.

Harriett Baldwin

There are 10 Military Annual Training Tests (MATTs) ranging from map reading and navigation through to Chemical, Biological, Radiation, Nuclear (CBRN) training. In 2015, 32 Army Reservists who had either not completed or failed an aspect of their MATTs were mobilised for deployment. The decision to deploy is made by the Chain of Command only on the basis that the gap in MATTs would not prevent them from safely and responsibly fulfilling their deployed role. In addition to MATTs, all deployed personnel receive an intensive programme of training specific to the operation.

In addition, 2 Medical brigade mobilised and deployed 122 medical Reserve personnel to Sierra Leone in a non-combat role in 2015, as part of the fight against Ebola. As part of its preparation the unit conducted its own MATTs for which pass and fail records are not held centrally and cannot readily be provided.

The below Parliamentary question was asked by Jim Shannon on 2016-10-11.

To ask the Secretary of State for Health, what steps he is taking to reduce the number of (a) obese and (b) overweight children under the age of 11; and if he will take steps to cooperate with (a) his counterparts in the devolved administrations, (b) GPs, (c) teachers and (d) parents to help reduce that number.

Nicola Blackwood

We launched Childhood Obesity: A Plan for Action on 18 August. Our plan focuses on actions that are likely to have the biggest impact on reducing childhood obesity and maintaining a healthy weight. It presents a bold package of policy proposals, informed by the available evidence. We will work with the devolved administrations, general practitioners and other healthcare professionals, teachers and parents to improve the health and wellbeing of children across the United Kingdom.

We are confident that the measures announced will make a real difference and estimate that they could reduce childhood obesity rates by around a fifth (330,000) over the next 10 years.

A copy of Childhood Obesity: A Plan for Action is attached and is available at:

www.gov.uk/government/uploads/system/uploads/attachment_data/file/546588/Childhood_obesity_2016__2__acc.pdf

“

The below Parliamentary question was asked by Jim Shannon on 2016-10-17.

To ask the Secretary of State for Health, what assessment his Department has made of the potential effect of slow medicine reimbursement decisions on the level of commercial investment in UK clinical research by companies specialising in rare and ultra-rare conditions.

Nicola Blackwood

Independent evidence suggests that the most important attraction for companies to invest in research in the United Kingdom is the availability of world-class scientific expertise, which is the focus of the Government’s effort to ensure the UK remains at the forefront of global Research and Development. It also suggests that there is no obvious reason why National Health Service reimbursement policy for pharmaceuticals, or the time taken to make decisions on reimbursement, should significantly affect decisions to invest in Research and Development in the UK.

The independently chaired Accelerated Access Review makes recommendations to the Government on reforms to accelerate access for NHS patients to innovative medicines, medical technologies, diagnostics and digital products.

The below Parliamentary question was asked by Jim Shannon on 2016-10-18.

To ask the Secretary of State for Foreign and Commonwealth Affairs, what discussions he has had with his US and other NATO counterparts on the nuclear tests being conducted by North Korea; and what steps he is taking to help prevent North Korea’s development of a nuclear arsenal.

Alok Sharma

Following the Democratic People’s Republic of Korea (DPRK) conducting its fifth nuclear test on 9 September, the Secretary of State for Foreign and Commonwealth Affairs, my Rt Hon. Friend the Member for Uxbridge and South Ruislip (Boris Johnson), made clear that the UK strongly condemned the test, which is a flagrant violation of binding UN Security Council (UNSC) Resolutions. The UK has worked closely with international partners for many years to respond to the nuclear weapons and missile programmes of the DPRK.

The UNSC agreed wide-ranging sanctions following the fourth nuclear test in January, which contained some of the strongest measures the UNSC has ever adopted. As I said on 23 September at the UN Security Council meeting, "there is now a need to work immediately on further significant measures." The UK is working with international partners on further significant measures the UNSC can take in response to the fifth test.

The below Parliamentary question was asked by Jim Shannon on 2015-11-04.

To ask the Secretary of State for Environment, Food and Rural Affairs, what discussions she has had with the fisheries Minister in the Northern Ireland Executive on the level of cod stocks in the Irish Sea.

George Eustice

Defra holds regular discussions on a wide range of fisheries issues, including cod stocks, with counterparts in the Northern Ireland Executive. We are currently working together to prepare for the annual European fisheries negotiations that will take place in Brussels on 14-15 December 2015.

The below Parliamentary question was asked by Jim Shannon on 2015-11-03.

To ask the Secretary of State for Health, what discussions he has had with manufacturers of drugs for the treatment of AIDS on preventing rises in the prices of such drugs.

George Freeman

There have been no such representations or discussions. The prices of branded medicines are controlled by the 2014 Pharmaceutical Price Regulation Scheme or under the statutory scheme established under the Health Service Branded Medicines (Control of Prices and Supply of Information) (No.2) Regulations 2008 and the Health Service Medicines (Information Relating to Sales of Branded Medicines etc.) Regulations 2007.

The below Parliamentary question was asked by Jim Shannon on 2015-11-09.

To ask the Secretary of State for Environment, Food and Rural Affairs, what discussions she has had with shooting bodies on ensuring an effective trap is developed to replace the Fenn trap.

Rory Stewart

Defra officials have held discussions with representatives of the shooting bodies, trap manufacturers and retailers to discuss alternatives to the Fenn trap. Defra is in the process of approving a replacement trap and has funded testing on a further two traps.

The below Parliamentary question was asked by Jim Shannon on 2015-11-09.

To ask the Secretary of State for Health, what steps he is taking to promote his Department’s strategies to prevent cancer.

Jane Ellison

One of the independent Cancer Taskforce report’s six strategic priorities is to “spearhead a radical upgrade in prevention and public health”. NHS England is currently working with partners across the health system to determine how best to take forward the recommendations of the report.

As part of putting in place a governance structure for delivery of the strategy, NHS England has appointed Cally Palmer as NHS National Cancer Director. She will lead the implementation of the strategy, as well as new cancer vanguards using outcomes-based commissioning to redesign care and patient experience. Ms Palmer is Chief Executive of the Royal Marsden Hospital.

Public Health England (PHE) runs a number of successful campaigns relating to cancer prevention.

The tobacco marketing programme runs a range of activity to highlight the health harms of smoking. This includes demonstrating the link between smoking and cancer, as well as encouraging smokers to make quit attempts and signposting them to proven NHS tools and services to help. These programmes have been shown to have a positive impact on reducing adult smoking prevalence.

PHE’s flagship social marketing campaign, Change4Life, aims to help families and children in England to eat well, move more, and live longer. Some cancers are highlighted as a health consequence within the campaign messaging. The campaign has enjoyed considerable success and unparalleled levels of engagement. Since its launch in 2009, more than 2.7 million people have signed up to Change4Life and it now has more than 200 national partners. Its tools and resources incentivise and encourage behaviour change.

These complement the Be Clear on Cancer campaigns (BCoC) that encourage symptom recognition and earlier general practitioner presentation. BCoC campaigns have been running since early 2011 and have covered a number of cancers nationally and regionally.

The below Parliamentary question was asked by Jim Shannon on 2015-11-10.

To ask the Secretary of State for Health, what recent research his Department has commissioned or conducted on the health effects of e-cigarettes.

Jane Ellison

The National Institute for Health Research is currently funding a randomised controlled trial to examine the efficacy of e-cigarettes compared with nicotine replacement therapy, when used within the United Kingdom stop smoking service. The report of the trial is expected to be published in 2018.

Public Health England commissioned a comprehensive independent review of the latest evidence on e-cigarettes from leading academics. Their report, published on 19 August 2015, included the latest evidence on the safety and health effects of e-cigarettes.